The growth of the Public Cloud Infrastructure Managed Service Market is driven by the increasing adoption of cloud technologies across industries, the rising need...
The growth of the Public Cloud Infrastructure Managed Service Market is driven by the increasing adoption of cloud technologies across industries, the rising need...
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.
New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals
SYDNEY, Aug. 13, 2025 /PRNewswire/ --...
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or pre-funded warrants in lieu thereof) through an underwritten public offering. All of the shares of common stock (or pre-funded warrants in lieu thereof) are being offered by the Company. The completion of the offering remains subject to market conditions, with no assurance regarding its timing, size, or terms. The Company intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.
JOHNS CREEK, Ga., Aug. 13, 2025 /PRNewswire/ -- A.D.A.M. Consumer Health (A.D.A.M.), part of the global Ebix Group, has successfully passed and maintained its...
OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national...
TAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical technologies and medical device components announced today the launch of its Biomedical Textiles Innovation Lab, a state-of-the-art facility designed to help OEM partners rapidly prototype, test, and optimize textile-based medical materials.
New capabilities boost patient experience and safety, reduce clinician burden and unlock operational insight across hospitals
OXFORD, England, Aug. 13, 2025 /PRNewswire/ -- Oxehealth, a...
Juvent joins the 2025 Inc. 5000, ranking #757 with 552% growth over 3 years, for its Micro-Impact Platform, which improves mobility, pain, and wellness.
– Webcasted Q2-2025 conference call scheduled for August 26th at 5:00 PM EDT –
TORONTO and DALLAS, Aug. 11, 2025 /PRNewswire/ - Perimeter Medical Imaging AI,...
– Webcasted Q2-2025 conference call scheduled for August 26th at 5:00 PM EDT –
TORONTO and DALLAS, Aug. 11, 2025 /CNW/ - Perimeter Medical Imaging AI,...
IRVINE, Calif., Aug. 11, 2025 /PRNewswire/ -- The Dot Corp. is proud to announce it has earned ISO 9001:2015 certification, further solidifying its position...